Description
KLK11 Antibody | 47-134 | Gentaur UK, US & Europe Distribution
Host: Rabbit
Reactivity: Human
Homology: N/A
Immunogen: Synthetic peptide corresponding to aa residues 68-82 of human Hippostatin conjugated to KLH at the C-terminus.
Research Area: Cancer
Tested Application: N/A
Application: N/A
Specificiy: N/A
Positive Control 1: N/A
Positive Control 2: N/A
Positive Control 3: N/A
Positive Control 4: N/A
Positive Control 5: N/A
Positive Control 6: N/A
Molecular Weight: N/A
Validation: N/A
Isoform: N/A
Purification: N/A
Clonality: Polyclonal
Clone: N/A
Isotype: N/A
Conjugate: Unconjugated
Physical State: Liquid
Buffer: PBS containing 0.02% sodium azide.
Concentration: N/A
Storage Condition: This antibody is stable for at least one (1) year at -20˚C. Avoid multiple freeze-thaw cycles.
Alternate Name: CYCE2
User Note: Optimal dilutions for each application to be determined by the researcher.
BACKGROUND: Hippostatin, also known as KLK11, is a kallikrein-like serine protease, which has two alternatively spliced isoforms, brain-type and prostate-type. Hippostatin plays a role in the prostate, including reproductive and/or tumorigenic functions. Elevated serum levels of KLK11 were found in 70% of women with ovarian cancer and in 60% of men with prostate cancer. Analysis of the KLK11 biomarker in serum may aid in the diagnosis and monitoring of ovarian and prostatic carcinoma.